EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)Open Access

Long-Term Effects of Extended-Release Pemafibrate Tablets on Dyslipidemia and Safety in Triglyceridemic Patients: A Phase 3, Multicenter, Randomized, Open-Label, Parallel-Group Study

Hidenori Arai, Shizuya Yamashita, Eiichi Araki, Koutaro Yokote, Ryohei Tanigawa, Ayumi Saito, Daisuke Furukawa, Hideki Suganami, Shun Ishibashi

Journal of Atherosclerosis and Thrombosis · 2025

DOI: 10.5551/jat.65350 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2025. Verfasst von Hidenori Arai und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Geriatrics and Gerontology. Hauptthemen laut MEDLINE: Dyslipidemias, Triglycerides, Benzoxazoles, Butyrates. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyslipidemiasTriglyceridesBenzoxazolesButyratesHypolipidemic AgentsHumansMaleFemaleMiddle AgedDelayed-Action PreparationsTabletsAgedFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

Extended releaseLong-term effectPemafibrateSelective PPARα modulatorTriglycerides

Substanzen

Delayed-Action PreparationsTabletsTriglycerides(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acidBenzoxazolesButyratesHypolipidemic Agents

Autor:innen und Institutionen

  • National Center for Geriatrics and Gerontology.
  • Department of Cardiology, Rinku General Medical Center.
  • Kikuchi Medical Association Hospital.
  • Research Center for Health and Sports Sciences, Kumamoto Health Science University.
  • Chiba University.
  • Global Clinical Development Department, Kowa Company, Ltd.

Zitieren

APA

Arai, H., Yamashita, S., Araki, E., Yokote, K., Tanigawa, R., Saito, A., Furukawa, D., Suganami, H., & Ishibashi, S. (2025). Long-Term Effects of Extended-Release Pemafibrate Tablets on Dyslipidemia and Safety in Triglyceridemic Patients: A Phase 3, Multicenter, Randomized, Open-Label, Parallel-Group Study. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.65350

Vancouver

Arai H, Yamashita S, Araki E, Yokote K, Tanigawa R, Saito A, et al. Long-Term Effects of Extended-Release Pemafibrate Tablets on Dyslipidemia and Safety in Triglyceridemic Patients: A Phase 3, Multicenter, Randomized, Open-Label, Parallel-Group Study. Journal of Atherosclerosis and Thrombosis. 2025. doi:10.5551/jat.65350

BibTeX
@article{Arai2025,
  author = {Arai, Hidenori and Yamashita, Shizuya and Araki, Eiichi and Yokote, Koutaro and Tanigawa, Ryohei and Saito, Ayumi and Furukawa, Daisuke and Suganami, Hideki and Ishibashi, Shun},
  title = {Long-Term Effects of Extended-Release Pemafibrate Tablets on Dyslipidemia and Safety in Triglyceridemic Patients: A Phase 3, Multicenter, Randomized, Open-Label, Parallel-Group Study},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2025},
  doi = {10.5551/jat.65350}
}
Kostenlos starten →